Jane Street
ANGO icon

Jane Street’s AngioDynamics ANGO Stock Holding History

Jane Street’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Buy
+18,000
New +$195K ﹤0.01% 10098
2025
Q4 		– Sell
-17,100
Closed -$191K – 11028
2025
Q3 		$191K Buy
+17,100
New +$165K ﹤0.01% 9717

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Jane Street's ANGO Position: Q1 2026 in Review

Jane Street reduced its AngioDynamics (ANGO) stake by 66% in Q1 2026, selling an estimated $2.16M and leaving 101,934 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #6200.

Jane Street first reported a position in ANGO in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.86M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Jane Street held 101,934 shares of AngioDynamics worth $1.16M as of Q1 2026.
  • Jane Street sold 198,966 AngioDynamics shares in Q1 2026, an estimated $2.16M.
  • AngioDynamics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6200 holding.
  • Jane Street first reported a position in AngioDynamics in Q2 2021 and has held it in 16 quarters since.
  • Jane Street's AngioDynamics position peaked at $3.86M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.